Search results
Hemophilia A:
HEPA-Remove®
Heparin and heparin-like molecules interfere with various assays including coagulation assays and PCR-based assays. HEPA-Remove®has been designed to eliminate these interferences. Moreover, HEPA-Remove®inhibits FXII activation in aPTT based assays. For research use only.
HEMOCLOT VII-X
Vitamin K deficiency. Vitamin K antagonists. Isolated factor VII or X deficiency. Accelerated clotting factor consumption (DIC).
HEMOCLOT VII-X
Vitamin K deficiency. Vitamin K antagonists. Isolated factor VII or X deficiency. Accelerated clotting factor consumption (DIC).
HEMOCLOT Thrombin Time LRT
In vitro qualitative determination of thrombin time in human citrated plasma, using a manual or automated method.
HEMOCLOT Thrombin Time 8 (Conventional/bovine Thrombin)
Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.
HEMOCLOT Thrombin Time 2 (Conventional/bovine Thrombin)
Conventional thrombin time, highly sensitive to heparins and thrombin inhibitors.
HEMOCLOT Quanti. V-L
Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.